Design and use of methods for peptide secretion studies

肽分泌研究方法的设计和使用

• 批准号: 8010457
• 负责人: ROBERT T KENNEDY
• 金额: $ 10.02万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-02-04 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8010457
• 关键词: Adipocytes; Alpha Cell; Amino Acids; Anions; Autoimmune Process; Beta Cell; Biochemical; Biological Assay; Blood capillaries; Capillary Electrophoresis; Cell Communication; Cell Culture Techniques; Cell Line; Cell physiology; Cells; Cellular biology; Chemicals; Circadian Rhythms; Clinical; Coculture Techniques; Collaborations; Communication; Computers and Advanced Instrumentation; Coupled; Defect; Detection; Diabetes Mellitus; Electrophoresis; Endocrine; Evaluation; Event; Fatty Acids; Fluorescence; Funding; Genes; Glucose; Goals; Hormones; Immunoassay; Insulin; Insulin-Dependent Diabetes Mellitus; Islet Cell; Islets of Langerhans; Kinetics; Laboratories; Lasers; Lipids; Liquid Chromatography; Mass Spectrum Analysis; Measurement; Measures; Medical; Metabolic; Metabolic Pathway; Metabolism; Methods; Microfluidics; Modeling; Monitor; Non-Insulin-Dependent Diabetes Mellitus; Oxygen Consumption; Pancreas; Pathway interactions; Pattern; Peptides; Phase; Physiological; Physiology; Plant Roots; Reagent; Regulation; Relative (related person); Research; Research Personnel; Resolution; System; Techniques; Technology; Testing; Time; Tissues; Transplantation; Work; analytical method; base; capillary; cell type; cost; design; improved; instrumentation; insulin secretion; interest; islet; metabolomics; new therapeutic target; novel; paracrine; peptide hormone; programs; response; sensor; tool

A hallmark of Type 2 diabetes is impaired insulin secretion from beta cells of the islets of Langerhans. Type 1 diabetes is characterized by autoimmune attack on beta cells and subsequent loss of insulin secretion. A promising treatment for type 1 diabetes is transplant of islets; however, this treatment is presently limited by inability to adequately assess islets used in transplant. Greater understanding of islets and insulin secretion is of fundamental importance in determining the root causes of diabetes and developing potential treatments. Studies of islets are critically dependent upon instrumentation that can detect their biochemical and physiological dynamics. The overall objective of this work is to develop advanced instrumentation suitable for measuring chemical events related to peptide secretion from islets of Langerhans. Our first two aims are to develop microfluidic tools that will allow single islets to be cultured while simultaneously monitoring hormone and metabolite secretion and metabolism. To allow cell-cell interactions to be studied, the microfluidic chip will incorporate a microcirculatory system that allows two different cell types to be cultured and interact during the measurements. Our third aim is to develop a metabolomic method for simultaneous measurement of polar anionic compounds known to be critically involved in glucose-stimulated insulin secretion. The method will be based on multi-dimensional separations and mass spectrometry detection. Our final aim is to use these methods in collaborative studies including characterization of islets that may be used for transplant with the goal of determining if the measurements may be useful for islet assessment and determining the effect of key gene knock-outs on islet physiology. These methods will offer new opportunities for studying the root causes of diabetes and devising novel treatments. LAY SUMMARY. Diabetes is an enormous medical problem afflicting at least 8 million people and costing over $100 billion in 2002 in the US. Diabetes is characterized by impaired insulin secretion from cell clusters known as islets of Langerhans. Our research will result in novel instrumentation that will allow studies of the chemical changes associated with normal and diseased islet function in unprecedented detail. Assessment of such chemical changes is expected to help identify novel therapeutic targets.

2型糖尿病的一个标志是胰岛β细胞的胰岛素分泌受损。 1型糖尿病的特点是自身免疫攻击β细胞和随后的胰岛素损失 分泌物1型糖尿病的一种有希望的治疗方法是胰岛移植;然而， 目前受限于不能充分评估用于移植的胰岛。更好地了解胰岛 胰岛素分泌在确定糖尿病的根本原因和发展中起着至关重要的作用。 潜在的治疗。胰岛的研究严重依赖于能够检测其 生物化学和生理动力学。 这项工作的总体目标是开发先进的仪器，适用于测量化学 与胰岛肽分泌相关的事件。我们的前两个目标是开发微流体 这些工具将允许培养单个胰岛，同时监测激素和代谢物 分泌和代谢。为了研究细胞间的相互作用，微流控芯片将包含一个 微循环系统，允许两种不同的细胞类型被培养，并在培养过程中相互作用。 测量.我们的第三个目标是发展一种代谢组学方法， 已知阴离子化合物与葡萄糖刺激的胰岛素分泌密切相关。该方法将 基于多维分离和质谱检测。我们的最终目标是利用这些 合作研究中的方法，包括表征可用于移植的胰岛， 目的是确定测量是否可用于胰岛评估，并确定 胰岛生理学的关键基因敲除。这些方法将为根的研究提供新的机会 糖尿病的病因和设计新的治疗方法。 奠定总结。糖尿病是一个巨大的医疗问题，至少有800万人受到影响， 2002年在美国耗资超过1000亿美元。糖尿病的特征是细胞分泌胰岛素受损 被称为朗格汉斯岛。我们的研究将产生新的仪器， 对与正常和患病胰岛功能相关的化学变化进行了前所未有的详细研究。 对这种化学变化的评估有望帮助确定新的治疗靶点。